Long-term effects of multiple intravitreal antivascular endothelial growth factor injections on intraocular pressure

American Journal of Ophthalmology

Volumn 157, Issue 6, 2014, Pages

  Kim, Yoon Jeon ^a   Sung, Kyung Rim ^a   Lee, Kyoung Sub ^a   Joe, Soo Geun ^a   Lee, Joo Yong ^a   Kim, June Gone ^a   Yoon, Young Hee ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; SILICONE OIL;

AGED; AQUEOUS HUMOR OUTFLOW; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANK SUM TEST; REFRACTION ERROR; REFRACTIVE SURGERY; RETINA ARTERY; RETINA MACULA AGE RELATED DEGENERATION; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK FACTOR; SUBRETINAL FLUID; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; RETINAL VEIN OCCLUSION; RETREATMENT; RETROSPECTIVE STUDIES; TONOMETRY, OCULAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84901753322     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2014.02.035     Document Type: Article

References (18)

1. P.J. Rosenfeld, D.M. Brown, and J.S. Heier et al. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
2. D.M. Brown, P.K. Kaiser, and M. Michels et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444
3. R.D. Jager, L.P. Aiello, S.C. Patel, and E.T. Cunningham Jr. Risks of intravitreous injection: a comprehensive review Retina 24 5 2004 676 698
4. C.R. Group, D.F. Martin, and M.G. Maguire et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
5. J.E. Kim, A.V. Mantravadi, E.Y. Hur, and D.J. Covert Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents Am J Ophthalmol 146 6 2008 930 934 e931
6. S.J. Bakri, J.S. Pulido, C.A. McCannel, D.O. Hodge, N. Diehl, and J. Hillemeier Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab Eye 23 1 2009 181 185
7. Q.V. Hoang, L.S. Mendonca, K.E. Della Torre, J.J. Jung, A.J. Tsuang, and K.B. Freund Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections Ophthalmology 119 2 2012 321 326
8. T.J. Good, A.E. Kimura, N. Mandava, and M.Y. Kahook Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents Br J Ophthalmol 95 8 2011 1111 1114
9. A. Deobhakta, and L.K. Chang Inflammation in retinal vein occlusion Int J Inflam 2013 2013 438412
10. R.S. Singh, and J.E. Kim Ocular hypertension following intravitreal anti-vascular endothelial growth factor agents Drugs Aging 29 12 2012 949 956
11. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr., M. Feinsod, D.R. Guyer, and Group VISiONCT Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 27 2004 2805 2816
12. S.J. Wehrli, K. Tawse, M.H. Levin, A. Zaidi, M. Pistilli, and A.J. Brucker A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab Retina 32 7 2012 1295 1301
13. R.A. Adelman, Q. Zheng, and H.R. Mayer Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections J Ocul Pharmacol Ther 26 1 2010 105 110
14. J.J. Tseng, S.K. Vance, and K.E. Della Torre et al. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration J Glaucoma 21 4 2012 241 247
15. D.Y. Choi, M.C. Ortube, and C.A. McCannel et al. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib Retina 31 6 2011 1028 1035
16. D. Mitry, C. Bunce, and D. Charteris Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion Cochrane Database Syst Rev 1 2013 CD009510
17. S.S. Hayreh, M.B. Zimmerman, M. Beri, and P. Podhajsky Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion Ophthalmology 111 1 2004 133 141
18. S.J. Bakri, C.A. McCannel, A.O. Edwards, and D.M. Moshfeghi Persisent ocular hypertension following intravitreal ranibizumab Graefes Arch Clin Exp Ophthalmol 246 2008 955 958